Product Information
CLOMIPRAMINE 50 MG CAPSULE is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.2581 per EA under NDC 62332040831. Its NADAC has been published 259 times since Oct 20, 2021.
FDA first approved this application on Aug 4, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332040831
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CLOMIPRAMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211822FDA Approved
8/4/2021
TE Code
AB
On Market Since
8/5/2021
Pharmacological Classes
Price Statistics
The NADAC for CLOMIPRAMINE 50 MG CAPSULE has been published 259 times since Oct 20, 2021, and over the history we have for it it has declined 86.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2581 per EA |
|---|---|
| All-time high | $1.8513 (Dec 15, 2021) |
| All-time low | $0.2016 (May 22, 2024) |
| 52-week high | $0.2915 |
| 52-week low | $0.2257 |
| Median price | $0.3196 |
| Average price | $0.4365 |
| Largest weekly change | -56.5% (Nov 23, 2022) |
| Weeks tracked | 259 |
| Tracking since | Oct 20, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CLOMIPRAMINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tricyclic Antidepressant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOMIPRAMINE 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CLOMIPRAMINE 50 MG CAPSULE, manufactured by Alembic Pharmaceuticals Inc., is $0.2581 per EA (NDC 62332040831), effective Sep 30, 2026.
How has the price of CLOMIPRAMINE 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CLOMIPRAMINE 50 MG CAPSULE has declined 86.1%. It has been tracked across 259 weekly CMS publications since Oct 20, 2021.
What are the highest and lowest recorded NADAC prices for CLOMIPRAMINE 50 MG CAPSULE?
Since Oct 20, 2021, the NADAC for CLOMIPRAMINE 50 MG CAPSULE has ranged from a low of $0.2016 (May 22, 2024) to a high of $1.8513 (Dec 15, 2021), with a median of $0.3196 per EA.
Are there cheaper alternatives to CLOMIPRAMINE 50 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CLOMIPRAMINE 50 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures CLOMIPRAMINE 50 MG CAPSULE?
CLOMIPRAMINE 50 MG CAPSULE (NDC 62332040831) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.